Teneligliptin mitigates diabetic cardiomyopathy by inhibiting activation of the NLRP3 inflammasome

Figure 2 Teneligliptin improved heart function in streptozotocin-induced diabetic mice. A: The results of HE staining, Scale bar = 50 µm; B-D: Mice heart fractional shortening, ejection fraction, and heart rate was measured by echo. ^aP < 0.05 vs control group; ^bP < 0.05 vs streptozotocin group, n = 8. STZ: Streptozotocin.